Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group StudyJOURNAL OF RHEUMATOLOGYIF3.42021-05-152OA
Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCTHEALTH TECHNOLOGY ASSESSMENTIF42020-11-019OA
Patient and Caregiver Priorities for Medication Adherence in Gout, Osteoporosis, and Rheumatoid Arthritis: Nominal Group TechniqueARTHRITIS CARE & RESEARCHIF3.32020-09-2920OAAI
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic ReviewJOURNAL OF RHEUMATOLOGYIF3.42019-12-1513OAAI
Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trialLANCETIF88.52019-05-01162OAAI
Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence GroupJOURNAL OF RHEUMATOLOGYIF3.42019-01-154OAAI